摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-(2-呋喃基)丙烯酰基)苯丙氨酸 | 4950-66-7

中文名称
N-(3-(2-呋喃基)丙烯酰基)苯丙氨酸
中文别名
——
英文名称
fa-Phe
英文别名
(2S)-2-{[(E)-3-(2-furyl)-2-propenoyl]amino}-3-phenylpropanoic acid;N-(3-(2-Furyl)acryloyl)phenylalanine;(2S)-2-[[(E)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoic acid
N-(3-(2-呋喃基)丙烯酰基)苯丙氨酸化学式
CAS
4950-66-7
化学式
C16H15NO4
mdl
——
分子量
285.299
InChiKey
QSMRHXUZHXEHBK-VFNNOXKTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    206 °C
  • 沸点:
    547.8±50.0 °C(Predicted)
  • 密度:
    1.271±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    79.5
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-(fur-2-yl)crotonic acidsodium hydroxide 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 反应 24.0h, 生成 N-(3-(2-呋喃基)丙烯酰基)苯丙氨酸
    参考文献:
    名称:
    Efficient peptide coupling method of conjugated carboxylic acids with methyl ester amino acids hydrochloride. Application to the synthesis of Fa-Met, an important enzymatic substrate
    摘要:
    Benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate reagent (BOP) serves as an efficient and versatile coupling reagent for the coupling Of Conjugated carboxylic acid with methyl ester amino acids hydrochloride allowing the synthesis of various Substituted amino acid derivatives in high chemical yields of up to 90%. The usefulness of this method is illustrated in the synthesis of Fa-Met, an important enzymatic substrate. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2004.11.082
点击查看最新优质反应信息

文献信息

  • Metallo-proteinase inhibitory agent
    申请人:Société des Produits Nestlé S.A.
    公开号:EP1359157A1
    公开(公告)日:2003-11-05
    The present invention relates to an active agent, in particular a metalloproteinase inhibitory agent comprising casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria. The invention also relates to the manufacture of a agent, in which a food grade bacteria of the genus Lactobacillus helveticus is contacted with casein in order to perform an hydrolysis and obtain casein-derivated peptides exhibiting metalloproteinases inhibitory property. The present invention also concern the isolated and purified inhibitory peptides obtained by hydrolysis of casein by the said bacteria.
    本发明涉及一种活性剂,特别是一种金属蛋白酶抑制剂,该活性剂包含通过食品级细菌水解酪蛋白而获得的酪蛋白衍生肽。本发明还涉及一种制剂的制造,在这种制剂中, helveticus 乳酸杆菌属的食品级细菌与酪蛋白接触,以进行水解并获得具有金属蛋白酶抑制特性的酪蛋白衍生肽。本发明还涉及通过上述细菌水解酪蛋白获得的分离和纯化的抑制肽。
  • Renin-angiotensin system in diabetes mellitus
    申请人:——
    公开号:US20030158090A1
    公开(公告)日:2003-08-21
    The present invention provides novel methods of treatment of diabetes mellitus as well as methods of diagnosing the susceptibility of hypoglycaemia in an individual. The method of treatment includes administering to an individual a sufficient amount of at least one inhibitor of the renin-angiotensin II system and at least one antidiabetic, for example insulin. Another objective of the present invention is to provide methods of preventing hypoglycaemia in an individual in need thereof comprising administering to said individual a pharmaceutical effective amount of an inhibitor of the renin-angiotensin II system. In particular, such an individual may be an individual suffering from diabetes mellitus. A further objective of the present invention is to provide methods to diagnose the susceptibility to hypoglycaemia of an individual comprising detecting within a predetermined tissue sample the genotype of the angiotensin-converting enzyme (ACE) gene; or detecting within a predetermined tissue sample the activity of ACE; and correlating said genotype or activity to the susceptibility of hypoglycaemia.
    本发明提供了治疗糖尿病的新方法以及诊断个体低血糖易感性的方法。治疗方法包括向个体施用足量的至少一种肾素-血管紧张素 II 系统抑制剂和至少一种抗糖尿病药物,例如胰岛素。本发明的另一个目的是为有需要的个体提供预防低血糖症的方法,包括向所述个体施用药物有效量的肾素-血管紧张素 II 系统抑制剂。特别是,这种人可能是糖尿病患者。本发明的另一个目的是提供诊断个体低血糖易感性的方法,包括在预定组织样本中检测血管紧张素转换酶(ACE)基因的基因型;或在预定组织样本中检测血管紧张素转换酶的活性;以及将所述基因型或活性与低血糖易感性相关联。
  • Metalloproteinase inhibitory agent
    申请人:Juillerat Marcel-Alexandre
    公开号:US20050187155A1
    公开(公告)日:2005-08-25
    The present invention relates to an active agent, in particular a metalloproteinase inhibitory agent of casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria. The invention also relates to the manufacture of an active agent, in which a food grade bacteria of the genus Lactobacillus helveticus is contacted with casein in order to perform a hydrolysis and obtain casein-derived peptides exhibiting metalloproteinases inhibitory property. The present invention also includes isolated and purified inhibitory peptides obtained by hydrolysis of casein by the bacteria.
    本发明涉及一种活性剂,特别是通过食品级细菌水解酪蛋白获得的酪蛋白衍生肽的金属蛋白酶抑制剂。本发明还涉及一种活性剂的制造方法,其中一种食品级细菌属于 螺旋乳杆菌 与酪蛋白接触,以进行水解并获得具有金属蛋白酶抑制特性的酪蛋白衍生肽。本发明还包括通过细菌水解酪蛋白获得的分离纯化的抑制肽。
  • Preparation and Synthetic Applications of N-(α,β-Unsaturated Acyl)-α-amino Acid Derivatives
    作者:Alan R. Katritzky、Reena Gyanda、Nabin K. Meher、Yuming Song
    DOI:10.3987/com-08-s(f)109
    日期:——
    N-(alpha,beta-Unsaturated acyl)-alpha-amino acids, amides and esters are structural motifs of many biologically active natural products. An alternate and advantageous approach for the synthesis of N-(alpha,beta-unsaturated acyl)-alpha-amino acid derivatives is developed via acylation of unprotected alpha-amino acids with stable crystalline N-(alpha,beta-unsaturated acyl)benzotriazole. The proposed methodology provides a new synthesis for compound (9) which is a precursor to a novel cytotoxic agent.
  • KUNUGI, S.;TANABE, K.;FUKUDA, M.;MAKIMOTO, S.;TANIGUCHI, Y., J. CHEM. SOC. CHEM. COMMUN.,(1987) N 18, 1335-1336
    作者:KUNUGI, S.、TANABE, K.、FUKUDA, M.、MAKIMOTO, S.、TANIGUCHI, Y.
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物